Thyrocare Technologies enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


8,205	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
164	190	155	146	140
−1.0	0.5	0.3	0.9	0.9
0.0	0.0	0.0	21.6	0.0
8,041	—	—	—	—
−164	−190	−155	−124	−140
₹505.16	—	—	—	—

552	586	547	549	535
0.0%	0.0%	0.0%	3.9%	0.0%

8.64×	—	—	—	—
26.85×	—	—	—	—
33.81×	—	—	—	—
41.80×	—	—	—	—
930	829	687	572	527
299	262	190	137	120
238	203	135	90.4	81.3
—	213	191	168	129
192	192	146	106	85.7
—	192	146	104	85.0
—	20.9	44.9	61.6	43.7

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

THYROCARE₹515.50

Thyrocare Technologies Ltd.

· Pharma & Health

₹ CrorePeersLALPATHLAB METROPOLIS VIJAYA SUPRIYA VIYASH STAR SPARC YATHARTHMcap ₹8,205 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	8,205.2
- Cash, Equiv & ST Investments	140.1	146.1	155.0	189.8	163.6
+ Minority Interest	0.9	0.9	0.3	0.5	-1.0
+ Total Debt	0.0	21.6	0.0	0.0	0.0
Enterprise Value	—	—	—	—	8,040.6
Net Debt (memo)	-140.1	-124.5	-155.0	-189.8	-163.6
EV per Share	—	—	—	—	505.16

Total Capital	535.2	549.2	547.1	586.0	552.4
Total Debt/Total Capital	0.00	3.93	0.00	0.00	0.00

EV/Sales	—	—	—	—	8.64
EV/EBITDA	—	—	—	—	26.85
EV/EBIT	—	—	—	—	33.81
EV/Free Cash Flow	—	—	—	—	41.80
Reference Items — Trailing FY Values
Sales	526.7	571.9	687.4	829.0	930.3
EBITDA	120.1	137.4	190.4	262.0	299.5
EBIT	81.3	90.4	135.1	203.5	237.8
Operating Cash Flow	129.3	167.6	191.3	213.2	—
Free Cash Flow	85.7	106.1	146.4	192.4	192.4
FCFF (free cash flow to the firm)	85.0	104.2	146.3	191.7	—
Capital Expenditure	43.7	61.6	44.9	20.9	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.